JUNS

Jupiter Neurosciences, Inc. (OTC:JUNS) is a clinical-stage biotechnology company founded in 2016 and headquartered in Jupiter, Florida. Originally established as Jupiter Orphan Therapeutics, Inc., the company rebranded to its current name in August 2021 to better reflect its focus on neurological conditions. Jupiter Neurosciences went public in January 2022 and specializes in developing treatments for rare neurological diseases and neurodegenerative conditions using a resveratrol-based platform technology.